
Jan Christop L. Merene
Examiner (ID: 18719, Phone: (571)270-5032 , Office: P/3733 )
| Most Active Art Unit | 3733 |
| Art Unit(s) | 3733, 3773 |
| Total Applications | 1047 |
| Issued Applications | 660 |
| Pending Applications | 88 |
| Abandoned Applications | 313 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10076243
[patent_doc_number] => 09114078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-25
[patent_title] => 'Methods and compositions for genetic and retinal disease'
[patent_app_type] => utility
[patent_app_number] => 12/381777
[patent_app_country] => US
[patent_app_date] => 2009-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7585
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12381777
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/381777 | Methods and compositions for genetic and retinal disease | Mar 16, 2009 | Issued |
Array
(
[id] => 5315919
[patent_doc_number] => 20090280517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'METHODS OF DIAGNOSIS AND PROGNOSIS FOR A MUSCULAR DYSTROPHY'
[patent_app_type] => utility
[patent_app_number] => 12/400356
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14812
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280517.pdf
[firstpage_image] =>[orig_patent_app_number] => 12400356
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/400356 | METHODS OF DIAGNOSIS AND PROGNOSIS FOR A MUSCULAR DYSTROPHY | Mar 8, 2009 | Abandoned |
Array
(
[id] => 5385704
[patent_doc_number] => 20090226949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'Single-cell biosensor for the measurement of GPCR ligands in a test sample'
[patent_app_type] => utility
[patent_app_number] => 12/398027
[patent_app_country] => US
[patent_app_date] => 2009-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19747
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226949.pdf
[firstpage_image] =>[orig_patent_app_number] => 12398027
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/398027 | Single-cell biosensor for the measurement of GPCR ligands in a test sample | Mar 3, 2009 | Abandoned |
Array
(
[id] => 6617645
[patent_doc_number] => 20100003316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS USING PLASMONICS ENHANCED PHOTOSPECTRAL THERAPY (PEPST) AND EXCITON-PLASMON ENHANCED PHOTOTHERAPY (EPEP)'
[patent_app_type] => utility
[patent_app_number] => 12/389946
[patent_app_country] => US
[patent_app_date] => 2009-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 32105
[patent_no_of_claims] => 439
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003316.pdf
[firstpage_image] =>[orig_patent_app_number] => 12389946
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/389946 | Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (PEPST) and exciton-plasmon enhanced phototherapy (EPEP) | Feb 19, 2009 | Issued |
Array
(
[id] => 6024274
[patent_doc_number] => 20110052600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'IL-17RA-IL-17RB ANTAGONISTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/918449
[patent_app_country] => US
[patent_app_date] => 2009-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 35424
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052600.pdf
[firstpage_image] =>[orig_patent_app_number] => 12918449
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918449 | IL-17RA-IL-17RB ANTAGONISTS AND USES THEREOF | Feb 19, 2009 | Abandoned |
Array
(
[id] => 6235434
[patent_doc_number] => 20100267138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'COMPOSITIONS AND METHODS COMPRISING A LIGAND OF CHEMERINR'
[patent_app_type] => utility
[patent_app_number] => 12/389354
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 33192
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267138.pdf
[firstpage_image] =>[orig_patent_app_number] => 12389354
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/389354 | COMPOSITIONS AND METHODS COMPRISING A LIGAND OF CHEMERINR | Feb 18, 2009 | Abandoned |
Array
(
[id] => 5952381
[patent_doc_number] => 20110033467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'COMPOSITIONS AND METHODS COMPRISING A LIGAND OF CHEMERINR'
[patent_app_type] => utility
[patent_app_number] => 12/389349
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 34248
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033467.pdf
[firstpage_image] =>[orig_patent_app_number] => 12389349
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/389349 | Methods of making an antibody that binds a chemerin polypeptide | Feb 18, 2009 | Issued |
Array
(
[id] => 10040319
[patent_doc_number] => 09081020
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'Mutant proteins and methods for selecting them'
[patent_app_type] => utility
[patent_app_number] => 12/866594
[patent_app_country] => US
[patent_app_date] => 2009-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13926
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12866594
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866594 | Mutant proteins and methods for selecting them | Feb 4, 2009 | Issued |
Array
(
[id] => 6264998
[patent_doc_number] => 20100297674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM'
[patent_app_type] => utility
[patent_app_number] => 12/864124
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9645
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297674.pdf
[firstpage_image] =>[orig_patent_app_number] => 12864124
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864124 | NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM | Jan 21, 2009 | Abandoned |
Array
(
[id] => 8784128
[patent_doc_number] => 08430968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-30
[patent_title] => 'Method of extracting starches and sugar from biological material using controlled cavitation'
[patent_app_type] => utility
[patent_app_number] => 12/357465
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2010
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12357465
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/357465 | Method of extracting starches and sugar from biological material using controlled cavitation | Jan 21, 2009 | Issued |
Array
(
[id] => 5458204
[patent_doc_number] => 20090258356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Modulators of the transporter ABCD3 for treating acne or hyperseborrhea'
[patent_app_type] => utility
[patent_app_number] => 12/320174
[patent_app_country] => US
[patent_app_date] => 2009-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5917
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258356.pdf
[firstpage_image] =>[orig_patent_app_number] => 12320174
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/320174 | Modulators of the transporter ABCD3 for treating acne or hyperseborrhea | Jan 20, 2009 | Abandoned |
Array
(
[id] => 4595516
[patent_doc_number] => 07981629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-19
[patent_title] => 'Methods of isolating dermal papilla cells'
[patent_app_type] => utility
[patent_app_number] => 12/352985
[patent_app_country] => US
[patent_app_date] => 2009-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23167
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/981/07981629.pdf
[firstpage_image] =>[orig_patent_app_number] => 12352985
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/352985 | Methods of isolating dermal papilla cells | Jan 12, 2009 | Issued |
Array
(
[id] => 5480645
[patent_doc_number] => 20090203602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Compositions and methods for diagnosis and treatment of type 2 diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/319883
[patent_app_country] => US
[patent_app_date] => 2009-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 47285
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203602.pdf
[firstpage_image] =>[orig_patent_app_number] => 12319883
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/319883 | Compositions and methods for diagnosis and treatment of type 2 diabetes | Jan 11, 2009 | Abandoned |
Array
(
[id] => 5584990
[patent_doc_number] => 20090104192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Monoclonal Antibodies to Hepatocyte Growth Factor'
[patent_app_type] => utility
[patent_app_number] => 12/342059
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10811
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104192.pdf
[firstpage_image] =>[orig_patent_app_number] => 12342059
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/342059 | Monoclonal Antibodies to Hepatocyte Growth Factor | Dec 21, 2008 | Abandoned |
Array
(
[id] => 6165646
[patent_doc_number] => 20110195433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'Methods for Screening of Opioid Receptor Neutral Antagonists and Inverse Agonists and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/808852
[patent_app_country] => US
[patent_app_date] => 2008-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11223
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195433.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808852
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808852 | Methods for Screening of Opioid Receptor Neutral Antagonists and Inverse Agonists and Uses Thereof | Dec 15, 2008 | Abandoned |
Array
(
[id] => 5585417
[patent_doc_number] => 20090104619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Human G-Protein Coupled Receptors'
[patent_app_type] => utility
[patent_app_number] => 12/332174
[patent_app_country] => US
[patent_app_date] => 2008-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16278
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104619.pdf
[firstpage_image] =>[orig_patent_app_number] => 12332174
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/332174 | Human G-Protein Coupled Receptors | Dec 9, 2008 | Abandoned |
Array
(
[id] => 5393640
[patent_doc_number] => 20090210953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone, and/or vasopressin production or release'
[patent_app_type] => utility
[patent_app_number] => 12/328887
[patent_app_country] => US
[patent_app_date] => 2008-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 61518
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20090210953.pdf
[firstpage_image] =>[orig_patent_app_number] => 12328887
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/328887 | Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone, and/or vasopressin production or release | Dec 4, 2008 | Abandoned |
Array
(
[id] => 5422429
[patent_doc_number] => 20090148884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'LAT1 TRANSPORTERS EXPRESSED IN BLOOD BRAIN BARRIER CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/267503
[patent_app_country] => US
[patent_app_date] => 2008-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18420
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20090148884.pdf
[firstpage_image] =>[orig_patent_app_number] => 12267503
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/267503 | LAT1 TRANSPORTERS EXPRESSED IN BLOOD BRAIN BARRIER CELLS | Nov 6, 2008 | Abandoned |
Array
(
[id] => 5264413
[patent_doc_number] => 20090117098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Complement C1Q Inhibitors For The Prevention And Treatment Of Glaucoma'
[patent_app_type] => utility
[patent_app_number] => 12/262841
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3048
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20090117098.pdf
[firstpage_image] =>[orig_patent_app_number] => 12262841
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/262841 | Complement C1Q Inhibitors For The Prevention And Treatment Of Glaucoma | Oct 30, 2008 | Abandoned |
Array
(
[id] => 5284445
[patent_doc_number] => 20090098120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Compositions and methods for the treatment of immune related diseases'
[patent_app_type] => utility
[patent_app_number] => 12/290404
[patent_app_country] => US
[patent_app_date] => 2008-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 106
[patent_figures_cnt] => 106
[patent_no_of_words] => 44422
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12290404
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/290404 | Compositions and methods for the treatment of immune related diseases | Oct 28, 2008 | Abandoned |